Shenzhen Mellow Hope Pharm Industrial Co., Ltd.

News

News

Trends

	Tel:+86-755-82720498 Fax:+86-755-82720321
	mellowhope@mellowhope.com www.mellowhope.com

在线咨询

Mellow Hope Signs with New Partner in Ethiopia

MellowHope Received the First Order for Pakistani Market

MellowHope Commenced Clinical Trials in Vietnam

MellowHope Obtained Meningitis Vaccine Registration in Pakistan

MellowHope Closed First Varicella Contract in Guatemala

Mellowhope Awarded Two Antibiotics Certificates For Chile

Mellowhope Acquired MEVAC-Vari Approval in Guatemala

' Cognistar ' Reached the Final Approval Stage in India

New Delivery of Hepatitis A vaccine (Brand name: Mevac A)

The Clinical Trial of Cerebroprotein Hydrolysate for Injection (NUTRIPROTEIN) finished in India

Participation in Chilean government tender of 2.5 million doses of influenza vaccine.

Clinical Trial for Cerebroprotein Hydrolysate for Injection

Clinical Trial Protocol for MMR Vaccine Expected to Approve in the Second Quarter, 2009

Company Registration Approval Obtained from Vietnam (FDA)

MEVAC-OPV Enters Guatemala Market

Influenca Vaccine (MEVAC-FLU) Enters Chilean Market

HTDS Closes Acquisition of Mellow Hope

Total:17Records Page:1/1 PageSize:20Records 1